KEI Briefing Note 2022:3 Selected differences between Article 30, 31 and 44 of the WTO TRIPS Agreement as regards non-voluntary use of patented inventions
WTO TRIPS Agreement
International landscape of molnupiravir patents
(For more resources, please see our page on molnupiravir.) KEI has built a dataset of patents related to molnupiravir based upon a study by Imran et al (2021), the Medicines Patent Pool (MPP) MedsPal database, and our own searches. Our… Continue Reading
Bolivia seeks to import COVID-19 vaccines from Biolyse, if Canada grants them a compulsory license
Today the government of Bolivia and Biolyse, a company based in Canada, signed an agreement to acquire COVID-19 vaccines manufactured by the company, if Canada grants them a compulsory license. Biolyse is a manufacturer of cancer drugs with the potential… Continue Reading
KEI Statement at WTO COVID-19 Vaccine Equity Event
On Wednesday April 14, 2021, the World Trade Organization hosted an event titled “COVID-19 and Vaccine Equity: What can the WTO contribute?” which featured three sessions concerning vaccine distribution, manufacturing, and looking forward at how the system could better address… Continue Reading
KEI Letter to New WTO Director-General on COVID-19 Response
On March 1, 2021, Knowledge Ecology International (KEI) sent a letter to Dr. Ngozi Okonjo-Iweala, the new Director-General of the World Trade Organization (WTO) regarding the WTO’s COVID-19 response. In the letter, KEI urged Dr. Ngozi to fully step into… Continue Reading
While a major victory for Australia and public health, the WTO Appellate Body failed to address the legal status of the Doha Declaration
On June 9, 2020, the World Trade Organization (WTO) Appellate Body circulated its reports relating to the Australia – Tobacco Plain Packaging cases. The reports issued the decision regarding the appeals brought by Honduras and the Dominican Republic against the… Continue Reading
WIPO side event, December 6, 2018, on the Implications of Article 27.3(a) of the WTO TRIPS Agreement on the patentability of gene and cell-based therapies
DATE: Thursday, 6 December 2018 TIME: 1:30 PM to 3 PM VENUE: Room B CONVENER: Knowledge Ecology International (KEI) Knowledge Ecology International (KEI) cordially invites you to attend our side event during negotiations of the 29th Session of the Standing… Continue Reading
US opposes safeguards in WIPO treaty for the blind that are included in ACTA, and Beijing treaty
I was in Geneva today, and was told by several delegates the US is opposing this language in the negotiating text (from the Annex) [Proposed Footnote: It is understood that Contracting Parties who are members of the World Trade Organization… Continue Reading
USTR Zoellick Letter to TACD IP Group Regarding WTO Compulsory Licensing Mechanism
Original page: http://www.cptech.org/ip/wto/p6/zoellick02102003.doc RECEIVED 24 FEB 2003 Executive Office of the President The United States Trade Representative Washington, DC 20508 February 10, 2003 Mr. James Love Co-Chair TACD IP-workinggroup TACD Secretariat 24 Highbury Crescent UK-London N5 1RXDear Mr. Love, Thank… Continue Reading
EC Pascal Lamy Letter in Response to TACD regarding WTO Export Issue 17 December 2002
Original page: http://www.cptech.org/ip/wto/p6/lamy12172002.doc Pascal Lamy Rue de la Loi,… Continue Reading